Myocardial infarction still remains the main cause of death in western countries, despite considerable progress in the stent development area in the last decades. For clarification of the underlying mechanisms and the development of new therapeutic strategies, the availability of valid animal models are mandatory. Since we need new insights into pathomechanisms of cardiovascular diseases under in vivo conditions to combat myocardial infarction, the validity of the animal model is a crucial aspect. However, protection of animals are highly relevant in this context. Therefore, we establish a minimally invasive and simple model of myocardial infarction in mice, which assures a high reproducibility and survival rate of animals. Thus, this models fulfils the requirements of the 3R principle (Replacement, Refinement and Reduction) for animal experiments and assure the scientific information needed for further developing of therapeutical strategies for cardiovascular diseases.
Introduction
Myocardial infarction is one of the main causes of death in industrialized countries. Despite undeniable progress of diagnostic and therapeutic approaches, cardiovascular diseases are still the major cause of mortality. Given the improved life expectancy and life-related risks, a continuous increase in the incidence of cardiovascular diseases is expected in the future. Therefore, there is a strong need to establish and validate novel approaches for the treatment of cardiovascular disease. The information of human studies suffer from its limitations, these studies generally are insufficient to explain and understand the mechanisms at the molecular level, being unable to provide solutions to these major health problems.
Moreover, basic research has been limited due to complexity and difficulty to reproduce the mechanisms of cardiovascular disease in the laboratory. Therefore, to increase our knowledge about the pathophysiology of cardiovascular diseases, it is essential to validate animal models 1, 2 . However, to identify all cascades of molecular events involved in the healing after myocardial infarction, analysis at different time points is necessary, causing a large number of animals experiments.
Myocardial infarction experiments are often performed by using animal models. Inducing myocardial infarction in small animals [3] [4] [5] [6] [7] [8] [9] [10] [11] is the most suitable and efficient model employed to investigate cellular and molecular events than large animal models. Moreover, no other species presents the availability of transgenic or knockout strains as mice 12 . These mouse models are highly useful in other diseases, including cardiovascular pathologies (such as atherosclerosis, in stent restenosis) 13, 14 . In addition, the low pregnancy period and the high number of progenies qualify mouse models as most attractive system to study molecular mechanisms of myocardial infarction 12 .
Nevertheless, the size of the heart in mice expects high precision of manipulation during microsurgery. Teaching such qualified and skilled surgery personnel is a time-consuming and work-intensive process. Therefore, we herein present a detailed microsurgery procedure, including tips and tricks to guide collaborators even with average qualifications, such as students or technicians to perform the complex myocardial infarction model in mice.
Initially, intubation is performed by means of a short cannula without using the tracheotomy. The thoracic incision is located in the intercostal area, avoiding injury of ribs or/and surrounding tissue. This sub-step is highly relevant to assure fast recovery and healing 15 . The ligature is made differential for chronic ischemia and ischemia/reperfusion models, for a high survival rate while still maintaining a significant infarction size. Our experience shows that using silk suture assures a higher reproducibility compared to cryo-injuries 16 .
In conclusion, the method described here is applicable in both chronic ischemia and ischemia/reperfusion models in small animals. The tips and tricks presented in this procedure are meant to enable personnel with even low or average qualification to apply it in small animal models.
1. Perform a skin incision less than 0.5 cm in the middle of a line between xyphoid and left axila. Use forceps to separate the muscle layer from the underlying ribs. 2. Perform a small incision between ribs by using a small scissor until the thoracic cavity is opened 17 . For chronic infarction, perform the incision in the 5 th intercostal space ( Figure 1C ) and/or for the ischemia/reperfusion model, in the 4 th intercostal space ( Figure 1D ): for an easier approach number from below the 2 th and the 3 th intercostal space, respectively).
3. Place the retractors into the incision to open thoracic cavity and to visualize the heart. 4. Carefully remove the pericardium to prevent excessive fibrotic processes. 5. Visualize the left descending coronary artery (LAD) as a deep positioned light red vessel. If the LAD cannot be visualized, consider some reference points to increase the reproducibility. 1. For chronic infarction model, place the ligature in the middle of the ventral side of the heart (between the auricle and apex), having as reference the vein as shown in Figure 1C . Bind both branches of the artery using 0/7 silk suture to obtain a transmural anterior and posterior infarction. The gray color indicates the position of the ligature and can be repeated if needed ( Figure 1C ). 2. For ischemia/reperfusion model, place the ligature under the auricle, over the main body of LAD ( Figure 1D ). The ligature is located over a silicon tube to protect the integrity of the vessel. The gray color indicates the infarcted area and should appear in the entire heart ( Figure 1D ). Place temporal sutures on the ribs during the ischemia period and moisten using a compress to avoid tissue drying. After ischemia, remove the silicon tube and cut the suture with small scissors to visualize the reperfusion.
6. Beside the anesthetics and analgesics used at the beginning of procedure (steps 2.1 and 2.2), use 0.5% isoflurane during surgery to ensure the proper comfort of the animal, or follow the animal care guidelines of your institution.
Suture and Recovery
1. Eliminate the residual air from thorax by filling with warm isotonic salt solution.
2. Close the thorax with 3 sutures 0/6 (as shown in Figure 2A and 2B). Position the medial sutures at an angle of 90°, to assure a sealed closure of the ribs, as shown in Figure 2 (Figure 2A, B) . 3. Close the muscle layer with 2 sutures (Figure 2C ) and the skin with 3-4 sutures 0/6 ( Figure 2D ). Perform these sutures separately to obtain a proper window for further echocardiographic measurement. 4. Disconnect the intubation cannula from the ventilator and allow spontaneous breath. For later identification, mark the mouse using the local system (ask the animal welfare officer from your institution). 5. Lay down the mouse on the left side under the red lamp until it wakes up. Do not leave an animal unattended until it has regained sufficient consciousness. Do not allow an animal that has undergone surgery to be in the company of other animals until fully recovered. 6. Manage pain therapy with buprenophine 0.1 mg/kg body weight, subcutaneously for the next 3 days, following the animal care guidelines of your institution.
1. Regularly monitor the heart function by means of echocardiography ( Figure 3A) : the ejection fraction, fractional shortening, cardiac output and heart dimensions. 2. Anesthetize the animals using intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine. Confirm proper anesthetization prior to surgery by the lack of reflexes. 3. Open the thoracic cavity and excise the heart, placing it in sterile PBS solution washing extensively the remaining blood. 4. If needed, collect the blood directly from the heart by avoiding the injury of the infracted regions, or after removal of the heart, from the thoracic cavity. 5. After washing, stop the heart in diastola in saturated KCl solution (steril filtered 3M KCl in PBS). For histological analysis fix the heart in 10% formalin and proceed with Step 5.7. 6. If necessary, measure the viability of the cardiac cells by Evans-Blue/ Triphenyl tetrazolium chloride (TTC) staining. After rebuilding the ligature at the initial place, perfuse the heart with 200 µl 1% Evans Blue Solution using an aortic cannula and freeze the heart in a small plastic bag at -20 °C, without washing. 1. After 2 hr, perform 5 transversally slides using a sharp scalpel and incubate them for 10-15 min in TTC solution at 37 °C, as described by manufactured. Fix the slides for 10 min in 10% formalin and put them between the microscopic slides for further analysis. 2. Embed the heart tissue in paraffin, by positioning the heart on the tip, to perform transversal sectioning. Perform serial section of 5 µm.
Collect the first 20 sections and discard the next 300 µm. Continue the section protocol until the mitral valve level has been reached ( Figure 3A, B) . Serial sections, 400 µm apart along the entire heart are collected and can be stained for the qualitative and quantitative analysis.
7. Measure the infarction size using Gomori's one-step staining [6] [7] [8] . 8. Analyze angiogenesis, collagen content or inflammatory cells recruitment in serial section using usual immunohistological staining.
Representative Results
The myocardial infarction procedure occurs within 25-30 min and shows a mortality rate of 10%. After surgery, the mice recover from anesthesia within the next 15 min. No physical impairment was observed to the operated mouse. However, there is a higher risk of heart rupture one week after post-chronic myocardial infarction, if the repairing processes are disturbed during the inflammatory phase. Since heart is able to change significantly its dimensions during the pumping, it is important for all the collected hearts to be stopped in the same position, for example in diastola. This can be achieved by perfusing the heart with saturated KCl solution. Increased extracellular K+ concentration blocks the ionic pumps, decreases the membrane resting potential of cardiac cells, resulting in a diastolic arrest of cardiac activity.
The infarction area can be seen in ultrasound analysis ( Figure 3A, lower panel) . In comparison to the normal myocardium, ischemic regions appear thin and hypokinetic ( Figure 3A, upper panel) . Depending on the model used, the infarction size will differ. The chronic infarction model induces circular, transmural infarction of the apex (Figure 3B) , while the ischemia/reperfusion induces a thin, middle-wall and throughout all heart ( Figure 3C ). There are many methods to determine infarction size. If the aim is to analyze the direct effect on cardiac viability, an EvansBlue/TTC staining 18 is indicated to be performed at least 2 hours after reperfusion, to be able to see any changes in the myocardium. Sections can be analyzed immediately ( Figure 3B , middle panel) after staining or can be kept between glass slides in formalin for 2-3 days ( Figure 3C , middle panel). The blue area represents the healthy myocardium, not affected by ischemia. The red area represents the viable myocardium inside the ischemic area (risk myocardium), and the white area represents the dead tissue. Usually, the infarction size is expressed as percent from the risk area.
The mature scar resulting after remodeling processes can be easily measured by immunohistolgy using Gomori's one-step staining. Blue-stained infarcted and red-stained healthy ventricular areas ( Figure 3B and C, right panels) are determined in the first section from each level until the mitral valve. To avoid the variation due to binding of LAD at different levels, the infarction from all section is considered and expressed as a percentage of total left ventricular volume. An infarction volume of 15-20% in chronic infarction model and of 10-15% after ischemia/reperfusion model can be achieved. Further, the chronic infarction model will induce an accentuated dilatation, not observed in the ischemic/reperfusion model ( Figure 3B and C right panel).
